↓ Skip to main content

The why, what, and how of the new FACT standards for immune effector cells

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
4 news outlets
twitter
28 X users
patent
1 patent

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The why, what, and how of the new FACT standards for immune effector cells
Published in
Journal for Immunotherapy of Cancer, April 2017
DOI 10.1186/s40425-017-0239-0
Pubmed ID
Authors

Marcela V. Maus, Sarah Nikiforow

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
United States 1 1%
Unknown 66 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 24%
Other 9 13%
Student > Ph. D. Student 7 10%
Student > Bachelor 5 7%
Professor 3 4%
Other 10 15%
Unknown 18 26%
Readers by discipline Count As %
Medicine and Dentistry 13 19%
Agricultural and Biological Sciences 8 12%
Biochemistry, Genetics and Molecular Biology 6 9%
Immunology and Microbiology 5 7%
Engineering 3 4%
Other 12 18%
Unknown 21 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2024.
All research outputs
#892,795
of 25,550,333 outputs
Outputs from Journal for Immunotherapy of Cancer
#212
of 3,460 outputs
Outputs of similar age
#18,052
of 324,349 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#6
of 25 outputs
Altmetric has tracked 25,550,333 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,460 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,349 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.